Wolverine Blend contains BPC-157 10MG and TB-500 10MG per vial, for a combined listed amount of 20MG.
COMING SOON
Wolverine combines BPC-157 10MG and TB-500 10MG in one vial: 20MG combined listed amount. These amounts describe composition, not a recommended dose.
Body Protection Compound-157 is a synthetic 15-amino-acid peptide associated with gastric-peptide research. Experimental research examines tissue responses, angiogenesis (new blood vessel formation), collagen-related biology, and gastrointestinal tissue responses.
TB-500 is associated with a synthetic fragment of thymosin beta-4. Research topics include cell migration and tissue remodeling. Findings for full-length thymosin beta-4 cannot automatically be applied to TB-500.
Tendon, ligament, and muscle tissue responses in experimental models.
Inflammatory pathways and connective-tissue biology. These topics do not establish relief of joint pain or inflammation in people.
Both components are listed in a single vial for laboratory research.
Research on individual components does not establish the safety or effectiveness of this combination in people. This product is not presented as an established injury-recovery or anti-inflammatory treatment. For laboratory research only. Not for human consumption or medical use.
Blend composition per vial: BPC-157 10MG and TB-500 10MG. The listed amounts describe product composition.
Any analytical report should be matched to the exact lot supplied. No purity or testing claim is implied without lot-specific supporting documentation.